SCHEMBL6842528

SCHEMBL6842528

C[S+]([O-])c1nccc(-c2ncsc2C#N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6839964 0.79 MYC (0.31) —
SCHEMBL6840019 0.73 EGFR (0.33) —
SCHEMBL5818004 0.70 MEN1 (0.33) —
SCHEMBL5813457 0.69 NPC1 (0.39) —
SCHEMBL5819177 0.68 MAPK14 (0.38) —
SCHEMBL6070023 0.68 TGFBR1 (0.32) —
SCHEMBL5815412 0.67 KMO (0.38) —
SCHEMBL5817042 0.67 RORB (0.38) —
SCHEMBL6840009 0.66 MEN1 (0.41) —
SCHEMBL27997668 0.65 AURKA (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040181066-A1 Tyrosine kinase inhibitors FRALEY MARK E (US) 2004-09-16 — — US disclosed
WO-2003011838-A1 TYROSINE KINASE INHIBITORS MERCK & CO., INC. (US) 2003-02-13 — — WO disclosed
Send feedback